News
PGNY
28.51
+4.13%
1.13
What Does the Sale of Progyny Shares by the CFO Mean for Investors?
The Motley Fool · 1d ago
Progyny Price Target Raised to $33.00/Share From $30.00 by Truist Securities
Dow Jones · 4d ago
Progyny Is Maintained at Buy by Truist Securities
Dow Jones · 4d ago
Truist Securities Maintains Buy on Progyny, Raises Price Target to $33
Benzinga · 4d ago
Truist Financial Sticks to Its Buy Rating for Progyny (PGNY)
TipRanks · 4d ago
PROGYNY INC <PGNY.O>: TRUIST SECURITIES RAISES TARGET PRICE TO $33 FROM $30
Reuters · 4d ago
Weekly Report: what happened at PGNY last week (0615-0619)?
Weekly Report · 4d ago
U.S. RESEARCH ROUNDUP-Baldwin Insurance Group, Diamondback Energy, Visteon
Reuters · 4d ago
Progyny (PGNY) Stock After Governance Shift And $200m Buyback What Does The Valuation Signal Now
Simply Wall St · 06/15 17:14
Weekly Report: what happened at PGNY last week (0608-0612)?
Weekly Report · 06/15 09:20
What Progyny (PGNY)'s Supermajority Rollback and US$200 Million Buyback Mean For Shareholders
Simply Wall St · 06/10 07:23
Weekly Report: what happened at PGNY last week (0601-0605)?
Weekly Report · 06/08 09:19
Progyny CFO Mark S. Livingston reports $99,295 common share disposal
PUBT · 06/05 20:39
Progyny EVP, General Counsel Allison Swartz disposes of 2,813 common shares worth $70,450.23
PUBT · 06/05 20:39
Progyny Insiders Quietly Unload Shares in Eye-Catching Stock Moves
TipRanks · 06/04 02:07
Progyny CFO Mark S. Livingston disposes of USD 11,444 in common shares
PUBT · 06/03 20:54
Progyny director Cheryl Scott disposes of 14,667 common shares worth $387,442.43
PUBT · 06/03 20:53
Progyny Chief Product Officer Geoffrey Clapp disposes of USD 39,137.4 in common shares
PUBT · 06/03 20:52
Assessing Progyny (PGNY) Valuation After A Sharp Share Price Rebound
Simply Wall St · 06/03 04:46
Progyny Is Maintained at Buy by B of A Securities
Dow Jones · 06/02 18:18
More
Webull provides a variety of real-time PGNY stock news. You can receive the latest news about Progyny, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About PGNY
Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.7 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.